medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2022, Number 1

<< Back Next >>

Rev Latin Infect Pediatr 2022; 35 (1)

Myocarditis due to COVID-19

Fierro FO, Loera AID

Language: Spanish
References: 20
Page: 22-25
PDF size: 201.83 Kb.


ABSTRACT

Myocarditis is the inflammation of the muscular layer of the heart wall and has a multiple etiology, among which, the most current and most medically relevant, thanks to the large number of cases that are occurring, are those caused by the SARS virus. CoV-2 discovered in 2019 in Wuhan, China and causing COVID-19. The number of cases of myocarditis associated with COVID-19 is increasing considerably, it presents clinically with dyspnea, fatigue, arrhythmias, heart failure data, among others. Studies such as ECG, ultrasound and MRI are suggested to establish a diagnostic suspicion and complement with myocardial biopsy to make the definitive diagnosis. Patient-specific treatment ranges from diuretics, ACE inhibitors, ARB-II, and corticosteroids, to ECMO therapy and heart transplantation in the case of unstable myocarditis.


REFERENCES

  1. Ross MH, Pawlina W. Histología. Texto y Atlas: correlación con biología celular y molecular. 7a ed. Barcelona, España: Wolters Kluwer; 2016. pp. 753-784.

  2. Kierszenbaum A, Tres L. Histología y biología celular: Introducción a la anatomía patológica. 4a ed. Barcelona: Elsevier; 2016. p. 750.

  3. Dominguez F, Kühl U, Pieske B, Garcia-Pavia P, Tschope C. Actualización sobre miocarditis y miocardiopatía inflamatoria: el resurgir de la biopsia endomiocárdica. Rev Española Cardiol. 2016; 69 (2): 178-187.

  4. Diaz D. Miocarditis asociada a COVID-19 [Internet]. 2021. Disponible en: https://www.sac.org.ar/consejos-cientificos/miocarditis-asociada-a-covid-19/

  5. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest [Internet]. 2009; 39 (7): 618-625. Available in: http://www.ncbi.nlm.nih.gov/pubmed/19453650

  6. Rizo GO. Miocarditis. Insuf Card. 2014; 9 (3): 134-142.

  7. Cooper LT Jr. Myocarditis. N Engl J Med [Internet]. 2009; 360 (15): 1526-1538. Available in: http://www.ncbi.nlm.nih.gov/pubmed/19357408

  8. Feldman AM, McNamara D. Myocarditis. N Engl J Med [Internet]. 2000; 343 (19): 1388-1398. Available in: http://www.ncbi.nlm.nih.gov/pubmed/11070105

  9. Blyszczuk P. Myocarditis in humans and in experimental animal models. Front Cardiovasc Med [Internet]. 2019; 6: 64. Available in: http://www.ncbi.nlm.nih.gov/pubmed/31157241

  10. University JH. COVID-19 data repository by the center for systems science and engineering (CSSE) [Internet]. 2021. Available in: https://github.com/CSSEGISandData/COVID-19

  11. Leonard EG. Viral myocarditis. Pediatr Infect Dis J. 2004; 23 (7): 665-666.

  12. Kariyanna PT, Sutarjono B, Grewal E, Singh KP, Aurora L, Smith L, et al. A systematic review of COVID-19 and myocarditis. Am J Med case reports [Internet]. 2020; 8 (9): 299-305. Available in: http://www.ncbi.nlm.nih.gov/pubmed/32747875

  13. Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol [Internet]. 2020; 311: 116-121. Available in: http://www.ncbi.nlm.nih.gov/pubmed/32291207

  14. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med [Internet]. 2020; 46 (5): 846-848. Available in: http://www.ncbi.nlm.nih.gov/pubmed/32125452

  15. Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, et al. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revasc Med [Internet]. 2021; 23: 107-113. Available in: http://www.ncbi.nlm.nih.gov/pubmed/32847728

  16. Bautista García J, Peña Ortega P, Bonilla Fernández JA, Cárdenes León A, Ramírez Burgos L, Caballero Dorta E. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Rev Esp Cardiol [Internet]. 2021; 74 (9): 812-814. Available in: http://www.ncbi.nlm.nih.gov/pubmed/33776190

  17. Irabien-Ortiz A, Carreras-Mora J, Sionis A, Pamies J, Montiel J, Tauron M. Fulminant myocarditis due to COVID-19. Rev Esp Cardiol (Engl Ed). 2020; 73 (6): 503-504.

  18. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34 (33): 2636-2648.

  19. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J [Internet]. 2011; 75 (3): 734-743. Available in: http://www.ncbi.nlm.nih.gov/pubmed/21304213

  20. Hsu KH, Chi NH, Yu HY, Wang CH, Huang SC, Wang SS et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience. Eur J Cardiothorac Surg [Internet]. 2011; 40 (3): 682-688. Available in: http://www.ncbi.nlm.nih.gov/pubmed/21334919




2020     |     www.medigraphic.com